Transparency Initiative Launched;FDA Describes What It Does;Genzyme Resumes Product Shipments;FDA to Take Another Look at Epo;New Type of Biologic Approved for Rheumatoid Arthritis;More Information to Be Available on Tysabri Complication;Nanotechnology Safety Act Introduced in Congress;Problems with GINA?;Anti-Bioterror Efforts Found Wanting;Teva Files for Biosimilar Filgrastim;When Can a Company Not Be Fined for Off-Label Promotion?;FDA Should Add Safety Symbol to Web Sites for Prescription Drugs;How Is Human DNA Used in Animals?

Abstract

Get full access to this article